Language:简体 / 繁體 / English

Hardworking for career launching; integrity-based operation; pioneering and innovative; strict obedience to the disciplines

Hardworking for career launching; integrity-based operation; pioneering and innovative; strict obedience to the disciplines


Hardworking for career launching; integrity-based operation; pioneering and innovative; strict obedience to the disciplines


Hardworking for career launching; integrity-based operation; pioneering and innovative; strict obedience to the disciplines


Hardworking for career launching; integrity-based operation; pioneering and innovative; strict obedience to the disciplines

Hardworking for career launching; integrity-based operation; pioneering and innovative; strict obedience to the disciplines


Products


I.The First Series: Anti-infective APIs & Intermediates

Cephalosporis

NO.

Compendial Name

Quality   Specification

CGMP   Status

International   Registration & Certification

 

CAS NO.

 

1

Cefoperazone Sodium

USP,EP,BP, CP

DMF available, and registered in India,   Egypt and Vietnam

62893-20-3

2

Cefuroxime Sodium

USP,EP, BP, CP, IP

DMF available, and   registered in India

56238-63-2

3

Ceftizoxime Sodium

USP, JP,CP

DMF available and registered in India,   Vietnam, Egypt.

68401-82-1

Intermediate

Ceftizoxime   acid

86299-50-5

4

Cefepime   Hydrochloride

USP,IP, CP

DMF   available, and registered in India, Egypt.

107648-80-6

5

Ceftazidime

USP,EP, BP, CP

DMF available, and   registered in India

78439-06-2

6

Cefotiam   Hydrochloride

USP, JP

DMF available, and   registered in Japan, Korea.

66309-69-1

Intermediate

Cefotiam   Hydrochloride crude


7

Ceftezole Sodium

CP

DMF available, and   registered in Korea.

41136-22-5

8

Cefazedone Sodium

KP

DMF available, and registered   in Korea, Vietnam

33564-30-6

Intermediate


Cefazedone acid

56187-47-4

9

Cefamandole

Nafate

USP,EP,BP, CP

DMF available, and   registered in India.

42540-40-9


NO.

Compendial Name

Quality   Specification


CGMP Status

 

International   Registration & Certification


CAS NO.

10

Cefathiamidine

CP


33075-00-2

Intermediate

Cefathiamidine Crude


11

Ceftriaxone Sodium

USP,EP ,JP,BP,CP

DMF available, and   registered in India.

104376-79-6

12

Cefotaxime Sodium

USP,EP BP, CP

DMF available, and   registered in India.

64485-93-4

13

Cefoxitin Sodium

USP,EP,BP, CP


33564-30-6

14

Cefonicid Sodium

USP , CP


61270-78-8

15

Cefodizime Sodium

JP


86329-79-5

16

Cefpirome Sulfate

JP


98753-19-6

17

Cefmenoxime

Hydrochloride

USP



75738-58-8

18

Cefminox Sodium

CP


75498-96-3

19

Cefpiramide

USP,JP


70797-11-4

20

Cefpiramide Sodium

JP



74849-93-7

21

Cephalothin Sodium

CP


58-71-9

22

Cefprozil

USP



121123-17-9


23

Cefetamet Pivoxil

JP



111696-23-2

24

Cefteram Pivoxil

JP



82547-58-8


NO.

Compendial Name

Quality   Specification


CGMP   Status

 


International   Registration & Certification


CAS NO.

 

25

Cefixime

USP,EP ,BP,CP, IP


79350-37-1

26

Cefdinir

USP



91832-40-5

27

Cefcapene Pivoxil Hydrochloride

JP



147816-24-8

28

Cefditoren Pivoxil

JP



117467-28-4

29

Ceftibuten

JP



97519-39-6

30

Cefmetazole Sodium

CP



56796-39-5


Quinolone   APIs



NO.

 

Compendial Name

Quality Specification

CGMP   Status


International   Registration & Certification

CAS NO.

 

31

Moxifloxacin Hydrochloride

JP



186826-86-8

Intermediate

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic   acid ethyl ester

139693-52-0

32

Sitafloxacin

IH



127254-12-0

33

Balofloxacin

CP


127294-70-6

34

Prulifloxacin

CP


123447-62-1

35

Enoxacin Gluconate

CP


471-53-4

 Other   Anti-infective APIs & Intermediates


NO.

 

Compendial Name

Quality   Specification

CGMP Status


International Registration &   Certification


CAS NO.

 

36

Sulbactam Sodium

USP,EP , BP,CP

DMF available, and registered   in India, Korea.

69388-84-7

37

Tazobactam

CP



89786-04-9

38

Biapenem

JP


120410-24-4

39

Meropenem

CP



96036-03-2

40

Aztreonam (or with   L-arginine)

USP,CP ,IP

DMF available,and to be registered in Vietnam

----

Intermediate

δ- Aztreonam

78110-38-0

41

Nifutatel

CP


4936-47-4

Ⅱ.   The Second Series: Antiviral APIs & Intermediates

NO.

Compendial Name

 

Quality Specification

CGMP   Status

International   Registration & Certification

CAS NO.

 

1

Ganciclovir

USP,EP, BP,CP


82410-32-0

2

Lamivudine

USP,EP, BP

DMF available, and Registered in India.

134678-17-4

3

Tenofovir

Disoproxil

Fumarate

IP



 

202138-50-9

4

Entecavir

EP



142217-69-4

5

Telbivudine

EP



3424-98-4

Ⅲ. The Third Series: Respiratory System   APIs & Intermediates

 

NO.

Compendial Name

Quality Specification


CGMP   Status

 

 

International   Registration & Certification


CAS NO.

 

1

Ambroxol   Hydrochloride

EP, BP,CP

DMF available, registered in Japan

23828-92-4

2

Ciclesonide

EP



126544-47-6

Ⅳ. The Fourth Series: Digestive System APIs & Intermediates

NO.

Compendial Name

Quality Specification

 


CGMP   Status

 

International   Registration & Certification

CAS NO.

 

1

Omeprazole   Enteric-coated Pellets

USP


73590-58-6

2

Lansoprazole

USP, EP, BP


103577-45-3

3

Pantoprazole Magnesium

IP



1022083-88-0

4

Esomeprazole sodium

IP



161796-78-7

Intermediate

Omeprazole sulfide

73590-85-9

5

Esomeprazole Magnesium

USP , BP



161973-10-0

Intermediate

Esomeprazole magnesium trihydrate

217087-09-7

6

Rabeprazole Sodium

EP



117976-90-6

Intermediate


117977-21-6

Intermediate

Rabeprazole

117976-89-3

7

 (R)-Lansoprazole

IP



138530-94-6

8

Racecadotril

CP



81110-73-8

9

Tropisetron Hydrochloride

CP



105826-92-4

10

Tiopronin

CP


1953-02-2

Ⅴ.   The Fifth Series: Nervous System APIs & Intermediates

NO.

Compendial Name

Quality Specification

 

CGMP   Status

 

International   Registration & Certification

 

CAS NO.

 

1

Edaravone

JP



89-25-8

2

Menantine   Hydrochloride 

KP



41100-52-1

3

Donepezil Hydrochloride

USP



110119-84-1

4

Oxiracetam

JP



62613-82-5

Ⅵ. The Sixth Series: Endocrine   System APIs & Intermediates

 


NO.

Compendial Name

Quality Specification


CGMP   Status

 

International   Registration & Certification

 


CAS NO.

 

1

Vildagliptin

EP



274901-16-5

2

Nateglinide

USP, EP



105816-04-4

Intermediate 1


 

Nateglinide methyl   ester

105746-47-2

Intermediate 2

4-(4-Aminophenoxy)-N-methylpicolinamide

105816-04-4

3

Levothyroxine Sodium

USP,EP,BP


867-81-2

Ⅶ. The Seventh Series: Cardiovascular System   APIs & Intermediates

 

NO.

Compendial Name

Quality Specification

CGMP   Status

 

 

International   Registration & Certification

CAS NO.

 

1

Simvastatin

USP、CP



79902-63-9

2

Carbazochrome Sodium   Sulfonate

JP


51460-26-5

3

Fasudil Hydrochloride

CP


103745-39-7

4

Tirofiban Hydrochloride

USP



150915-40-5

5

Clopidogrel Hydrogen Sulfate

EP



120202-66-6

6

Ezetimibe

USP



163222-33-1

7

Creatine Phosphate Sodium

EP



922-32-7

8

Argatroban

JP



141396-28-3

9

Pitavastatin Calcium

JP



147526-32-7

10

Olmesartan   MedoxomiI

JP



144689-63-4

11

Dabigatran Etexilate

Mesylate

EP



872728-81-9

12

Ticagrelor

USP



274693-27-5

Intermediate

376608-74-1

13

Sotalol Hydrochloride

USP,EP,BP, CP


959-24-0

14

Tadalafil

USP



171596-29-5

Intermediate 1

14907-27-8

Intermediate 2

171752-68-4

Intermediate 3

171489-59-1

15

Sildenafil Citrate

USP



171599-83-0

Ⅷ. The   Eighth Series: Antipyretic, Analgesics and Anti-inflammatory APIs &   Intermediates


NO.

Compendial Name

Quality   Specification

CGMP Status


International   Registration & Certification


CAS NO.

 

1

Ketorolac   Tromethamine

USP



74103-07-4

2

Loxoprofen Sodium

JP



80382-23-6

3

Parecoxib   Sodium

EP



198470-85-8

4

Cisatracurium

Besilate

EP



96946-42-8

5

Nalmefene   Hydrochloride

USP



58895-64-0

6

Diflunisal

USP, EP



22494-42-2

7

Guacetisal

CP



55482-89-8

8

Olopatadine

Hydrocholoride

JP



113806-05-6

9

Sodium New   Houttuyfonate

IH


1847-58-1

Ⅸ. The Ninth Series: Oncology APIs   & Intermediates

NO.

Compendial Name

Quality Specification

CGMP   Status

International   Registration & Certification

CAS NO.

 

1

Gemcitabine

Hydrochloride

USP,EP,BP


122111-03-9

2

Irinotecan   Hydrochloride

USP


136572-09-3

3

Oxaliplatin

USP,EP, BP


61825-94-3

4

Erlotinib

Hydrochloride

JP



183319-69-9

Intermediate 1

179688-29-0

Intermediate 2

183322-18-1

Intermediate 3

Erlotinib   Base

183321-74-6

5

Sorafenib

Tosylate

EP



475207-59-1

Intermediate 1

4-(4-Aminophenoxy)-N-methylpicolinamide

284462-37-9

Intermediate 2

Sorafenib

284461-73-0

6

Gefitinib

EP



184475-35-2

7

Dasatinib

USP



863127-77-9

8

Lapatinib

Ditosylate

EP



388082-78-8

9

Capecitabine

USP



154361-50-9

10

Fosaprepitant

Dimeglumine

USP



265121-04-8

11

Bortezomib

JP, USP



179324-69-7

12

Lenalidomide

USP



191732-72-6

 

Intermediate

3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione

827026-45-9

X. The Tenth Series:Anti-allergicAPIs & Intermediates

1

Loratadine

USP,EP,BP, CP


79794-75-5